The Effect of Patient- and Treatment-Related Factors on Circuit Lifespan During Continuous Renal Replacement Therapy in Critically Ill Children
Authors:
- 11 March 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 21 (6) , 578-585
Abstract
Objectives: To examine the effects of patient and treatment variables on circuit lifespan in critically ill children requiring continuous renal replacement therapy. Design: Retrospective observational study based on a prospective registry. Setting: Tertiary referral 30-bed PICU. Patients: One hundred sixty-one critically ill children undergoing continuous renal replacement therapy during an 8-year period (2007–2014) were included in the study. Interventions: Continuous renal replacement therapy. Measurements and Main Results: During the study period, 161 patients received a total of 22,190 hours of continuous renal replacement therapy, with a median duration of 74.75 hours (interquartile range, 32–169.5) per patient. Of the 572 filter circuits used, 276 (48.3%) were changed due to circuit clotting and 262 (45.8%) were electively changed. Median circuit life was 24.62 hours (interquartile range, 10.6–55.3) for all filters and significantly longer for those electively removed as compared to those prematurely removed because of clotting (35.50 hr [interquartile range, 16.9–67.6] vs 22.00 hr [interquartile range, 13.8–42.5]; p < 0.001). Multivariate regression analyses revealed that admission diagnosis (p < 0.001), anticoagulation type (p < 0.001), access type (p = 0.016), and circuit size (p = 0.027) were associated with prolonged circuit life, as well as, in patients on heparin anticoagulation, with higher doses of heparin (p < 0.001) and a prolonged activated partial thromboplastin time (p < 0.001). Conclusions: In this study, circuit lifespan in pediatric continuous renal replacement therapy was low and appeared to depend upon the patient’s diagnosis, the type of access and anticoagulation used as well as the size of the circuit used.Keywords
This publication has 25 references indexed in Scilit:
- Citrate versus heparin anticoagulation in continuous renal replacement therapy in small childrenPediatric Nephrology, 2017
- Membrane pressures predict clotting of pediatric continuous renal replacement therapy circuitsPediatric Nephrology, 2017
- Regional citrate anticoagulation for continuous renal replacement therapy in childrenPediatric Nephrology, 2016
- Pediatric continuous renal replacement: 20 years laterIntensive Care Medicine, 2015
- Citrate anticoagulation for continuous renal replacement therapy in small childrenPediatric Nephrology, 2013
- Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failureJournal of Critical Care, 2012
- Regional Citrate Versus Heparin Anticoagulation for Continuous Renal Replacement Therapy: A Meta-Analysis of Randomized Controlled TrialsAmerican Journal of Kidney Diseases, 2012
- Continuous renal replacement therapy in childrenPediatric Nephrology, 2012
- Continuous renal replacement therapy (CRRT) in patients with liver disease: Is circuit life different?Journal of Hepatology, 2009
- Controversies in paediatric continuous renal replacement therapyIntensive Care Medicine, 2009